全文获取类型
收费全文 | 911篇 |
免费 | 78篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 36篇 |
妇产科学 | 8篇 |
基础医学 | 80篇 |
口腔科学 | 35篇 |
临床医学 | 87篇 |
内科学 | 238篇 |
皮肤病学 | 12篇 |
神经病学 | 14篇 |
特种医学 | 250篇 |
外科学 | 93篇 |
综合类 | 17篇 |
预防医学 | 32篇 |
眼科学 | 16篇 |
药学 | 27篇 |
肿瘤学 | 46篇 |
出版年
2023年 | 6篇 |
2022年 | 6篇 |
2021年 | 7篇 |
2020年 | 15篇 |
2019年 | 2篇 |
2018年 | 14篇 |
2017年 | 21篇 |
2016年 | 17篇 |
2015年 | 18篇 |
2014年 | 31篇 |
2013年 | 26篇 |
2012年 | 33篇 |
2011年 | 28篇 |
2010年 | 42篇 |
2009年 | 34篇 |
2008年 | 17篇 |
2007年 | 25篇 |
2006年 | 13篇 |
2005年 | 17篇 |
2004年 | 16篇 |
2003年 | 5篇 |
2002年 | 9篇 |
2001年 | 6篇 |
2000年 | 4篇 |
1999年 | 8篇 |
1998年 | 46篇 |
1997年 | 57篇 |
1996年 | 53篇 |
1995年 | 48篇 |
1994年 | 46篇 |
1993年 | 30篇 |
1992年 | 13篇 |
1991年 | 11篇 |
1990年 | 11篇 |
1989年 | 20篇 |
1988年 | 31篇 |
1987年 | 15篇 |
1986年 | 40篇 |
1985年 | 36篇 |
1984年 | 17篇 |
1983年 | 21篇 |
1982年 | 18篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1979年 | 2篇 |
1978年 | 7篇 |
1977年 | 11篇 |
1976年 | 16篇 |
1975年 | 4篇 |
1969年 | 1篇 |
排序方式: 共有995条查询结果,搜索用时 15 毫秒
51.
52.
53.
The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells 总被引:5,自引:0,他引:5
Interferons (IFNs) have been shown to have significant effects on hematopoietic cell growth. Previous studies defining these effects have utilized mouse and human alpha-, beta-, and gamma-IFN isolated from supernatants of stimulated cells. Despite purification, the possible presence of other lymphokines and soluble factors remains a concern. In this study, the effects of gene-cloned alpha- and gamma-IFN on colony- forming units of granulocyte/macrophage (CFU-GM) progenitors cultured from the peripheral blood of normal volunteers were examined. In addition, blast cell colonies from one patient with acute myelogenous leukemia (AML) were studied. The growth of normal CFU-GM and AML blast cell colonies was inhibited in a dose-dependent manner by gamma- and alpha-IFN. gamma-IFN was ten to 100 times more potent than alpha-IFN in that this species of IFN reduced colony formation by greater than 50% at concentrations of less than 15 antiviral U/mL. The effects of gamma- IFN were neutralized by a monoclonal antibody specific for gamma-IFN. These in vitro studies indicate that human gamma-IFN may be an important modulator of myelopoiesis. Although these data indicate a possible efficacy of gamma-IFN in the treatment of AML, the in vitro results should be considered for their in vivo significance. 相似文献
54.
Shalender Bhasin MB BS Thomas G. Travison PhD Todd M. Manini PhD Sheena Patel MS Karol M. Pencina PhD Roger A. Fielding PhD Jay M. Magaziner PhD Anne B. Newman MD MPH Douglas P. Kiel MD Cyrus Cooper DM FMedSci Jack M. Guralnik MD PhD Jane A. Cauley Dr.PH Hidenori Arai MD PhD Brian C. Clark PhD Francesco Landi MD PhD Laura A. Schaap PhD Suzette L. Pereira PhD Daniel Rooks PhD Jean Woo MD PhD Linda J. Woodhouse PhD Ellen Binder MD Todd Brown MD Michelle Shardell PhD Quian-Li Xue PhD Ralph B. DʼAgostino Sr PhD Denise Orwig PhD Greg Gorsicki PhD Rosaly Correa-De-Araujo MD PhD Peggy M. Cawthon PhD 《Journal of the American Geriatrics Society》2020,68(7):1410-1418
55.
H. A. Fink M. A. Kuskowski J. A. Cauley B. C. Taylor J. T. Schousboe P. M. Cawthon K. E. Ensrud For the Osteoporotic Fractures in Men Study Group 《Osteoporosis international》2014,25(12):2833-2839
Summary
Prior studies suggest an association between stressful life events and fractures that may be mediated by BMD. In the current study, risk of accelerated hip BMD loss was higher in older men with any type of stressful life event and increased with the number of types of stressful life events.Introduction
Prior studies suggest that stressful life events may increase adverse health outcomes, including falls and possibly fractures. The current study builds on these findings and examines whether stressful life events are associated with increased bone loss.Methods
Four thousand three hundred eighty-eight men aged ≥65 years in the Osteoporotic Fractures in Men study completed total hip bone mineral density (BMD) measures at baseline and visit 2, approximately 4.6 years later, and self-reported stressful life events data mid-way between baseline and visit 2, and at visit 2. We used linear regression to model the association of stressful life events with concurrent annualized total hip BMD loss, and log binomial regression or Poisson regression to model risk of concurrent accelerated BMD loss (>1 SD more than mean annualized change).Results
Men (75.3 %) reported ≥1 type of stressful life event, including 43.3 % with ≥2 types of stressful life events. Mean annualized BMD loss was ?0.36 % (SD 0.88), and 13.9 % of men were categorized with accelerated BMD loss (about 5.7 % or more total loss). Rate of annualized BMD loss increased with the number of types of stressful life events after adjustment for age (p?0.001), but not after multivariable adjustment (p?=?0.07). Multivariable-adjusted risk of accelerated BMD loss increased with the number of types of stressful life events (RR, 1.10 [95 % confidence interval (CI), 1.04–1.16]) per increase of one type of stressful life event). Fracture risk was not significantly different between stressful life event-accelerated bone loss subgroups (p?=?0.08).Conclusions
In these older men, stressful life events were associated with a small, dose-related increase in risk of concurrent accelerated hip bone loss. Low frequency of fractures limited assessment of whether rapid bone loss mediates any association of stressful life events with incident fractures. Future studies are needed to confirm these findings and to investigate the mechanism that may underlie this association. 相似文献56.
57.
58.
Scott R. Bauer MD ScM Peggy M. Cawthon PhD MPH Kristine E. Ensrud MD Anne M. Suskind MD MS John C. Newman MD PhD Howard A. Fink MD MPH Kaiwei Lu MS Rebecca Scherzer PhD Andrew R. Hoffman MD Kenneth Covinsky MD Lynn M. Marshall ScD For the Osteoporotic Fractures in Men Research Group 《Journal of the American Geriatrics Society》2022,70(4):1082-1094
59.
60.